Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
17.03
+0.60 (3.63%)
Jun 8, 2026, 10:48 AM EDT - Market open
Odyssey Therapeutics Revenue
In the year 2025, Odyssey Therapeutics had annual revenue of $2.98M, down -33.45%. Odyssey Therapeutics had revenue of $287.00K in the quarter ending December 31, 2023.
Revenue (ttm)
$2.98M
Revenue Growth
-33.45%
P/S Ratio
260.44
Revenue / Employee
$29,760
Employees
100
Market Cap
803.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.98M | -1.50M | -33.45% |
| Dec 31, 2024 | 4.47M | 3.44M | 331.24% |
| Dec 31, 2023 | 1.04M | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionODTX News
- 6 days ago - Wedbush bullish on Odyssey Therapeutics, initiates with an Outperform - TheFly
- 6 days ago - Wedbush bullish on Odyssey Therapeutics, initiates with an Outperform - TheFly
- 6 days ago - Odyssey Therapeutics initiated with an Outperform at Wedbush - TheFly
- 6 days ago - Odyssey Therapeutics initiated with an Outperform at Oppenheimer - TheFly
- 6 days ago - Odyssey Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 6 days ago - Odyssey Therapeutics initiated with a Buy at TD Cowen - TheFly
- 6 days ago - Odyssey Therapeutics initiated with an Overweight at JPMorgan - TheFly
- 4 weeks ago - Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut - Reuters